TCL Archive Medicare increases payments for oncology infusion and begins a one-year demonstration project that pays oncologists to assess the side effects of chemotherapy. November 5, 2004
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion May 31, 2002
TCL Archive Afinitor Significantly Reduced Tumor Size In TSC-Related Renal Angiomyolipomas January 25, 2013
